Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor

被引:164
作者
Lee, Frank J. S.
Pei, Lin
Moszczynska, Anna
Vukusic, Brian
Fletcher, Paul J.
Liu, Fang
机构
[1] Univ Toronto, Dept Neurosci, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[3] Univ Toronto, Dept Psychol, Toronto, ON, Canada
[4] Univ Toronto, Dept Physiol, Toronto, ON, Canada
[5] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
关键词
autoreceptor; catecholamine; dopamine; transport; uptake;
D O I
10.1038/sj.emboj.7601656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Altered synaptic dopamine levels have been implicated in several neurological/neuropsychiatric disorders, including drug addiction and schizophrenia. However, it is unclear what precipitates these changes in synaptic dopamine levels. One of the key presynaptic components involved in regulating dopaminergic tone is the dopamine transporter (DAT). Here, we report that the DAT is also regulated by the dopamine D2 receptor through a direct protein-protein interaction involving the DAT amino-terminus and the third intracellular loop of the D2 receptor. This physical coupling facilitates the recruitment of intracellular DAT to the plasma membrane and leads to enhanced dopamine reuptake. Moreover, mice injected with peptides that disrupt D2-DAT interaction exhibit decreased synaptosomal dopamine uptake and significantly increased locomotor activity, reminiscent of DAT knockout mice. Our data highlight a novel mechanism through which neurotransmitter receptors can functionally modulate neurotransmitter transporters, an interaction that can affect the synaptic neurotransmitter levels in the brain.
引用
收藏
页码:2127 / 2136
页数:10
相关论文
共 53 条
[1]   Treatment of ischemic brain damage by perturbing NMDA receptor-PSD-95 protein interactions [J].
Aarts, M ;
Liu, YT ;
Liu, LD ;
Besshoh, S ;
Arundine, M ;
Gurd, JW ;
Wang, YT ;
Salter, MW ;
Tymianski, M .
SCIENCE, 2002, 298 (5594) :846-850
[2]   Calcium-dependent inhibition of synaptosomal serotonin transport by the α2-adrenoceptor agonist 5-bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304) [J].
Ansah, TA ;
Ramamoorthy, S ;
Montañez, S ;
Daws, LC ;
Blakely, RD .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (03) :956-965
[3]  
Batchelor M, 1998, J NEUROSCI, V18, P10304
[4]   Addiction, dopamine, and the molecular mechanisms of memory [J].
Berke, JD ;
Hyman, SE .
NEURON, 2000, 25 (03) :515-532
[5]   Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method [J].
Breier, A ;
Su, TP ;
Saunders, R ;
Carson, RE ;
Kolachana, BS ;
de Bartolomeis, A ;
Weinberger, DR ;
Weisenfeld, N ;
Malhotra, AK ;
Eckelman, WC ;
Pickar, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2569-2574
[6]  
Carneiro AM, 2002, J NEUROSCI, V22, P7045
[7]   DIRECT IN-VIVO EVIDENCE THAT D2 DOPAMINE-RECEPTORS CAN MODULATE DOPAMINE UPTAKE [J].
CASS, WA ;
GERHARDT, GA .
NEUROSCIENCE LETTERS, 1994, 176 (02) :259-263
[8]   Dopamine D2 receptor-mediated inhibition of dopaminergic neurons in mice lacking D2L receptors [J].
Centonze, D ;
Usiello, A ;
Gubellini, P ;
Pisani, A ;
Borrelli, E ;
Bernardi, G ;
Calabresi, P .
NEUROPSYCHOPHARMACOLOGY, 2002, 27 (05) :723-726
[9]   THE DOPAMINE-D2 RECEPTOR - 2 MOLECULAR-FORMS GENERATED BY ALTERNATIVE SPLICING [J].
DALTOSO, R ;
SOMMER, B ;
EWERT, M ;
HERB, A ;
PRITCHETT, DB ;
BACH, A ;
SHIVERS, BD ;
SEEBURG, PH .
EMBO JOURNAL, 1989, 8 (13) :4025-4034
[10]   Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum [J].
Dickinson, SD ;
Sabeti, J ;
Larson, GA ;
Giardina, K ;
Rubinstein, M ;
Kelly, MA ;
Grandy, DK ;
Low, MJ ;
Gerhardt, GA ;
Zahniser, NR .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (01) :148-156